Infection

Summary

We support and deliver studies into the prevention, diagnosis and treatment of infections in all age groups and all levels of care.

Our research areas include studies of:

  • the development and treatment of acute and chronic infectious diseases
  • the prevention, treatment and control of hospital-acquired infections
  • using vaccines to prevent infections, particularly acute infectious diseases
  • the development of new diagnostic tests and in microbiology

Speciality lead

Effrossyni Gkrania-Klotsas is the Research Delivery Network (RDN) National Specialty Lead for infections.

Funding opportunities / funding calls

See the latest funding opportunities for infectious diseases and microbiology

Associate Principal Investigator (PI) Scheme

If you’re a healthcare professional, you could be eligible for our Associate PI Scheme

Help with research

Through the Research Delivery Network (RDN), you can get help with:

  • planning and delivering your research to achieve the greatest impact
  • recruiting patients for your study
  • costs for your study, if you are eligible. This could include money for extra staff, facilities or equipment

Find out more about the Services to support study delivery

Latest news

News

Scientists close in on blood test to stop spread of tuberculosis

News

New mpox vaccine being tested in the UK

News

New NIHR-supported malaria vaccine recommended by WHO

Case studies

Stories

PRCs achieve an average 95% patient retention rate in Moderna vaccine trial

Learn how Patient Recruitment Centres prioritise the participants’ experience to support excellent patient retention rates.

Stories

Preventing cancer by extending vaccination to boys

Evidence from NIHR-funded research contributed to a change in immunisation policy that made the human papillomavirus (HPV) vaccine available to boys as well as girls, potentially preventing more than 100,000 cancers over 50 years.

Stories

Rapid response and coordination of early phase clinical trials during COVID-19

The Respiratory Translational Research Collaboration (R-TRC) played a leading role in supporting coordinated efforts in the national search for drugs to treat severe COVID-19 disease.